The Technical AnalystExchange: NASDAQ Capital Market Sector: Healthcare Industry: Biotechnology
Xenetic Biosciences, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
-17.11% $7.46
/ 9 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 5.93 mill |
| EPS: | 0 |
| P/E: | 0 |
| Earnings Date: | Mar 30, 2023 |
| SharesOutstanding: | 0.795 mill |
| Avg Daily Volume: | 0.0003 mill |
| RATING 2024-04-09 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Neutral | |
| P/E: | Buy | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt | n/a | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE 0 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE 0 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 7.20 - 7.72 ( +/- 3.53%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-12-06 | Mizrahy Moshe | Buy | 2 500 | Stock Options |
| 2023-12-06 | Mizrahy Moshe | Sell | 0 | Common Stock |
| 2023-12-11 | Lockshin Curtis | Buy | 10 000 | Stock Options |
| 2023-12-11 | Eisenberg Jeffrey F | Buy | 20 000 | Stock Options |
| 2023-12-11 | Parslow James F | Buy | 10 000 | Stock Options |
| INSIDER POWER |
|---|
| 100.00 |
| Last 85 transactions |
| Buy: 3 035 890 | Sell: 29 452 |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $7.46 (-17.11% ) |
| Volume | 0.0000 mill |
| Avg. Vol. | 0.0003 mill |
| % of Avg. Vol | 5.45 % |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For XBIOW
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
XBIOW
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.